Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ABCL
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Andrew Booth Chief Financial Officer | ABCL AbCellera Biologics Inc. | Buy | 8,600 | $11.33 | $97.4K Buy | Form 4 ↗ |
| Nov 12, 2026 | Thermopylae Holdings Ltd. 10% owner | ABCL AbCellera Biologics Inc. | Buy | 60,565 | $11.54 | $698.9K Buy | Form 4 ↗ |
| Aug 24, 2026 | Michael R. Hayden Director | ABCL AbCellera Biologics Inc. | Buy | 53,613 | $10.64 | $570.4K Buy | Form 4 ↗ |
| Aug 18, 2026 | John S. Montalbano Director | ABCL AbCellera Biologics Inc. | Buy | 10,000 | $11.03 | $110.3K Buy | Form 4 ↗ |
| Aug 14, 2026 | Andrew Booth Chief Financial Officer | ABCL AbCellera Biologics Inc. | Buy | 37,200 | $10.32 | $383.9K Buy | Form 4 ↗ |
| Aug 12, 2026 | Michael R. Hayden Director | ABCL AbCellera Biologics Inc. | Buy | 46,387 | $10.37 | $481.0K Buy | Form 4 ↗ |
| May 14, 2026 | John S. Montalbano Director | ABCL AbCellera Biologics Inc. | Buy | 20,000 | $4.77 | $95.4K Buy | Form 4 ↗ |
| Feb 27, 2026 | Thermopylae Holdings Ltd. 10% owner | ABCL AbCellera Biologics Inc. | Buy | 38,000 | $3.44 | $130.7K Buy | Form 4 ↗ |
| Feb 27, 2026 | Andrew Booth Chief Financial Officer | ABCL AbCellera Biologics Inc. | Buy | 42,600 | $3.42 | $145.7K Buy | Form 4 ↗ |
| Feb 26, 2026 | Thermopylae Holdings Ltd. 10% owner | ABCL AbCellera Biologics Inc. | Buy | 177,457 | $3.27 | $580.3K Buy | Form 4 ↗ |
| Nov 26, 2025 | John S. Montalbano Director | ABCL AbCellera Biologics Inc. | Buy | 50,000 | $3.57 | $178.5K Buy | Form 4 ↗ |
| Mar 11, 2025 | Thermopylae Holdings Ltd. 10% owner | ABCL AbCellera Biologics Inc. | Buy | 343,631 | $2.16 | $742.2K Buy | Form 4 ↗ |
| Mar 10, 2025 | John S. Montalbano Director | ABCL AbCellera Biologics Inc. | Buy | 25,000 | $2.30 | $57.5K Buy | Form 4 ↗ |
| Mar 6, 2025 | John S. Montalbano Director | ABCL AbCellera Biologics Inc. | Buy | 60,000 | $2.34 | $140.4K Buy | Form 4 ↗ |
14 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:53 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances